FKDSF (Fukuda Denshi Co) EBIT: $177.1 Mil (TTM As of Mar. 2026)


FKDSF Fukuda Denshi Co Ltd FKDSF
83 GF Score
Price $42.55
GF Value $27.75
! 4 Warning Signs
View Full Analysis

What is Fukuda Denshi Co EBIT?

Fukuda Denshi Co FKDSF 83 EBIT is $177.1 Mil as of Mar. 2026. GuruFocus rates FKDSF with a GF Score™ of 83/100 and a GF Value™ of $27.75. The stock has 4 warning signs investors should review.

Fukuda Denshi Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $64.3 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $177.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Fukuda Denshi Co's annualized ROC % for the quarter that ended in Mar. 2026 was 19.78%. Fukuda Denshi Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 47.03%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Fukuda Denshi Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 11.88%.

Fukuda Denshi Co  (OTCPK:FKDSF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Fukuda Denshi Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=257.32 * ( 1 - 30.69% )/( (889.51 + 913.988)/ 2 )
=178.348492/901.749
=19.78 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1385.165 - 89.786 - ( 405.869 - max(0, 190.245 - 737.716+405.869))
=889.51

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1420.275 - 92.102 - ( 414.185 - max(0, 195.15 - 756.9+414.185))
=913.988

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Fukuda Denshi Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=257.396/( ( (391.951 + max(153.147, 0)) + (388.574 + max(160.944, 0)) )/ 2 )
=257.396/( ( 545.098 + 549.518 )/ 2 )
=257.396/547.308
=47.03 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(182.356 + 105.602 + 43.889) - (89.786 + 0 + 88.914)
=153.147

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(216.697 + 77.085 + 48.933) - (92.102 + 0 + 89.669)
=160.944

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Fukuda Denshi Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=177.106/1490.601
=11.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fukuda Denshi Co EBIT Related Terms

Fukuda Denshi Co EBIT Historical Data

* Premium members only.

The historical data trend for Fukuda Denshi Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fukuda Denshi Co EBIT Chart

Fukuda Denshi Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 200.38 188.82 180.35 182.33 170.68

Fukuda Denshi Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.24 30.34 44.80 37.62 64.35

FKDSF vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Fukuda Denshi Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fukuda Denshi Co EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Fukuda Denshi Co's EV-to-EBIT falls into.


FKDSF
83GF Score
Fukuda Denshi Co Ltd FKDSF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fukuda Denshi Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $177.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $177.1 Mil mean?
Fukuda Denshi Co (FKDSF) has a EBIT of $177.1 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Fukuda Denshi Co.
Is Fukuda Denshi Co's EBIT too high?
Fukuda Denshi Co's current EBIT is $177.1 Mil. Overall, Fukuda Denshi Co has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's EBIT compare to ABT and SYK?
Fukuda Denshi Co's EBIT of $177.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Fukuda Denshi Co. Fukuda Denshi Co's current EBIT is $177.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Fukuda Denshi Co (FKDSF) has a current EBIT of $177.1 Mil. The stock's GF Value™ is $27.75, compared to a current price of $42.55 — trading 53.3% above its estimated fair value. The current EBIT is $177.1 Mil. Fukuda Denshi Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Fukuda Denshi Co (FKDSF), the current EBIT is $177.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fukuda Denshi Co (FKDSF) Overvalued in 2026?

Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued. The current stock price of $42.55 is trading 53.3% above its estimated GF Value™ of $27.75.

Key valuation signals for FKDSF:

  • EBIT: $177.1 Mil
  • GF Value™: $27.75 vs. price of $42.55 (53.3% above fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the FKDSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fukuda Denshi Co Business Description

Other Exchanges 6960:Japan
Address 39-4, Hongo 3-chome, Bunkyo-ku, Tokyo, JPN, 113-8483
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
83GF Score

Get the complete analysis for FKDSF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$42.55
Price
$27.75
GF Value